UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates

European journal of pharmaceutical sciences, 2020-08, Vol.151, p.105421, Article 105421

2020

Volltextzugriff (PDF)

An overview of new antitubercular drugs, drug candidates, and their targets

Medicinal research reviews, 2020-01, Vol.40 (1), p.263-292

2020

Volltextzugriff (PDF)

A Tandem Ring Closure and Nitrobenzene Reduction with Sulfide Provides an Improved Route to an Important Intermediate for the Anti-Tuberculosis Drug Candidate Sutezolid

Organic process research & development, 2024-04, Vol.28 (4), p.1195-1204

2024

Volltextzugriff (PDF)

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China

International journal of infectious diseases, 2021-08, Vol.109, p.253-260

2021

Volltextzugriff (PDF)

Spectroscopic identification of intermediates and final products of the chiral pool synthesis of sutezolid

Journal of molecular structure, 2020-10, Vol.1217, p.128396, Article 128396

2020

Volltextzugriff (PDF)

The oxazolidinones: past, present, and future

Annals of the New York Academy of Sciences, 2011-12, Vol.1241 (1), p.48-70

2011

Volltextzugriff (PDF)

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022-11, Vol.1211, p.123456-123456, Article 123456

2022

Volltextzugriff (PDF)

Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis

AAPS PharmSciTech, 2023-06, Vol.24 (5), p.130-130, Article 130

2023

Volltextzugriff (PDF)

Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives

Current medicinal chemistry, 2015-12, Vol.22 (38), p.4379

2015

Volltextzugriff (PDF)

Enantioselective recognition of sutezolid by cyclodextrin modified non-aqueous capillary electrophoresis and explanation of complex formation by means of infrared spectroscopy, NMR and molecular modelling

Journal of pharmaceutical and biomedical analysis, 2019-05, Vol.169, p.49-59

2019

Volltextzugriff (PDF)

New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?

Pharmaceutics, 2024, Vol.16 (6), p.818

2024

Volltextzugriff (PDF)

Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2019-05, Vol.169, p.196-207

2019

Volltextzugriff (PDF)

The synthesis of sutezolid and eperezolid using proline catalyzed α-aminoxylation of an aldehyde

Journal of chemical sciences (Bangalore, India), 2022-06, Vol.134 (2), Article 56

2022

Volltextzugriff (PDF)

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer

Antimicrobial agents and chemotherapy, 2019-03, Vol.63 (3)

2019

Volltextzugriff (PDF)

In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China

Infection and drug resistance, 2021, Vol.14, p.4689-4697

2021

Volltextzugriff (PDF)

Evolving strategies for dose optimization of linezolid for treatment of tuberculosis

The international journal of tuberculosis and lung disease, 2016-12, Vol.20 (12), p.48

Nuermberger, E

2016

Volltextzugriff (PDF)

The early bactericidal activity of antituberculosis drugs

Expert review of anti-infective therapy, 2014-02, Vol.12 (2), p.223-237

2014

Volltextzugriff (PDF)

The Oxazolidinones

Antibacterials, 2018, Vol.26, p.97-121

2018

Volltextzugriff (PDF)

Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates

Mini reviews in medicinal chemistry, 2015-01, Vol.15 (14), p.1174

2015

Volltextzugriff (PDF)

Les nouveaux antituberculeux (2) : nouvelles molécules

Journal des anti-infectieux, 2013-09, Vol.15 (3), p.133-140

Veziris, N.

2013

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(19)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates

An overview of new antitubercular drugs, drug candidates, and their targets

A Tandem Ring Closure and Nitrobenzene Reduction with Sulfide Provides an Improved Route to an Important Intermediate for the Anti-Tuberculosis Drug Candidate Sutezolid

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China

Spectroscopic identification of intermediates and final products of the chiral pool synthesis of sutezolid

The oxazolidinones: past, present, and future

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis

Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis

Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives

Enantioselective recognition of sutezolid by cyclodextrin modified non-aqueous capillary electrophoresis and explanation of complex formation by means of infrared spectroscopy, NMR and molecular modelling

New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?

Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry

The synthesis of sutezolid and eperezolid using proline catalyzed α-aminoxylation of an aldehyde

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer

In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China

Evolving strategies for dose optimization of linezolid for treatment of tuberculosis

The early bactericidal activity of antituberculosis drugs

The Oxazolidinones

Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates

Les nouveaux antituberculeux (2) : nouvelles molécules

Suchergebnisse filtern